Puma Biotechnology, (NYSE:PBYI) is a $3.2 billion market cap company initially focused on developing tyrosine kinase inhibitor neratinib (PB272) for HER2 positive breast cancer. The company has conducted 11 clinical trials for its lead candidate, with over 2,000 patients contributing to a favorable risk-benefit profile, per inflection point clinical trial readouts over the past quarter. Oncologic Drugs Advisory Committee (ODAC) at FDA recently voted for approval of neratinib in HER2 positive extended adjuvant treatment of early stage breast cancer in May 2017. ODAC vote is not binding but carries strong weight in the decision-making process. Given FDA director Gottlieb's new aggressive policies regarding the slow and outdated drug approval process at FDA, this was seen by the market as a "sure thing". The company is advancing neratinib in discussions with EMA for European markets, with validation in August 2016. Other investigations include neratinib in combinatory therapy for metastatic breast cancer and in solid tumors as well.
Neratinib blocks signal cascades of epidermal growth factor receptors or EGFRs, specifically: HER1, HER2, HER3, and HER4. A number of studies are showing nice anti-tumor efficacy. Taken together with ODAC favor, Phase 3 result emphasis for neratinib which met primary endpoints appears to have led to the robust response in the market for high probability of FDA approval. Two-year disease-free survival showed a 2.4% improvement for neratinib versus placebo in ITT population. Five-year disease-free survival showed a 2.5% improvement. In HR+ patients, neratinib adjuvant therapy showed a two-year disease-free survival rate of 95.4% compared to 91.2% in placebo. Five-year disease-free survival conferred a 4.8% benefit. Two-year HR patients' disease-free survival showed a meaningful advantage, but five-year data was not statistically significant.
The company recently presented data June 3 at ASCO 2017 summarizing positive results of its Phase 2 trial in HER2-positive metastatic breast cancer that has metastasized to the brain. Nearly half of the patients in a neratinib plus chemotherapy cohort achieved a central nervous system (CNS) objective response with overall survival data remaining immature at 13.5 months (and counting). CNS progressions remain a huge comorbidity factor in patients with brain metastases. With the ability to cross the blood-brain barrier, and with diarrhea being the number one adverse event, PBYI is well-positioned to advance in this space with neratinib. Studies examining antidiarrheal prophylaxis (Loperamide) to reduce diarrhea severity during neratinib treatment have proven effective. Phase 3 data showed grade 3 diarrhea decreased from ~40% to ~31% with loperamide, to ~23% with loperamide and budesonide, and to 11.5% with loperamide and colestipol. Safety studies examining children and young adults with cancer are also ongoing.
Multiple studies are generating impressive cancer therapy data for neratinib, including clinical data presented at AACR on neratinib in the treatment of patients who have solid tumors with activating HER2 or HER3 mutations. Additional data was also presented on the combination of T-DM1 and neratinib in patients with HER2 positive metastatic breast cancer (MBC) that has previously been treated with pertuzumab and trastuzumab. The company has done extensive analysis of breast cancer NSABP FB-7 biomarker during neratinib treatment with a variety of immuno and chemotherapy regimens to qualify its objective tumor response. Mechanistically, phosphoHER2 levels and truncated HER2 mutants (p95HER2) demonstrated statistically significant higher levels in patients who achieved a pCR with neratinib than those treated with trastuzumab or trastuzumab plus neratinib who did not. Moreover, dual pathway suppression (HR/ER+ and EGFR/HER2+) has been seen only in neratinib and not in Herceptin and Tykerb (Novartis (NYSE:NVS)).
The company has listed other potential tissue types to expand its label for neratinib, including non-small cell lung cancer, colorectal cancer, and solid tumors (any HER2-associated tumors). Roche (OTCQX:RHHBY) annual sales for Herceptin (trastuzumab) approach $5 billion. In contrast, Tykerb has not fared as well due to its unfavorable toxicity profile, with sales in the hundreds of millions. The HER2 positive breast cancer market is estimated to be about $13 billion by 2023. Given this massive market and plenty of room to expand label into other high dollar indications, Puma may still have quite a bit of upside and is generally de-risked. It certainly becomes very attractive on any stock price pullbacks.
Puma reported at end of 1Q 2017 cash and cash equivalents of $105.1 million and marketable securities of $88.9 million, with a 1Q net loss of $72 million. Cash runway is expected to last through mid-2018, with a burn rate of approximately $35 million per quarter. If the company is forced to raise funds, it should be able to do so at a good market value, given the advanced stage of its drug development. Strong Bio recommends a watch list spot for the stock and manageable delays or setbacks as a potential buying opportunity. Moreover, it may be a takeover candidate and could undergo some downward volatility in the standard process of stop-loss triggering. Such swoons will probably not last long as market support should be strong. With market cap of $3 billion and potential market quite a bit larger, there is plenty of room for value position here if sales meet expectations.
Risks for the company to investors are primarily centered around its one-trick pony pipeline. But when the trick is good enough, it's going to bring bank. Its advantage in efficacy will certainly gain a reasonable stake in the market for those that can tolerate the adverse events. In fact, the adverse event of diarrhea is somewhat severe, but luckily, most of that risk was mediated with appropriate prophylaxis regimen. It perhaps would have contraindications for those with extreme inflammatory bowel or related disorders. FDA-related large scale manufacturing risks and regulatory hurdles could prove to add delays and pitfalls to Puma's terrain, and since this is the only revenue-maker in its pipeline, a lot hinges on its expeditious advancement. However, given the aggressive stance at FDA to get life-saving therapies available to patients, most regulatory risks are ameliorated. Partnership decisions will be important inflection points moving forward.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.
Read more:
Puma Stalks Up - Puma Biotechnology, Inc. (NYSE:PBYI) | Seeking ... - Seeking Alpha
- 001 Stem Cell Therapy: Age of Human Cell Engineering is Born [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 002 Angel Biotechnology (ABH) - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- 003 Future of Health Care - medical, health and hospital trends - Biotechnology company keynote 2002 by - Video [Last Updated On: November 18th, 2011] [Originally Added On: November 18th, 2011]
- 004 Philippines banks on biotechnology to deal with enviromentally friendly issues, food security considerations [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 005 Biotechnology: Boon to Human being [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 006 Growth and development of Biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 007 Biotechnological innovation on Farming Skill [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 008 Curing the entire world through biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 009 India emerging as a global hub for stem cell research [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- 010 Scientists make ethical stem cells from skin of a rat [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- 011 South Korea again gives a go ahead to use of human eggs in cloning research [Last Updated On: February 5th, 2012] [Originally Added On: February 5th, 2012]
- 012 Angel Biotechnology - Contracts with Materia Medica [Last Updated On: February 6th, 2012] [Originally Added On: February 6th, 2012]
- 013 Cellerant Therapeutics Appoints Lowell E. Sears to Board of Directors [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 014 Angel Biotechnology - Grant of Share Options [Last Updated On: February 28th, 2012] [Originally Added On: February 28th, 2012]
- 015 RBCC Closes Deal with Game Changing Biotech Firm [Last Updated On: March 15th, 2012] [Originally Added On: March 15th, 2012]
- 016 Biotechnology Screencast Session 5.m4v - Video [Last Updated On: March 20th, 2012] [Originally Added On: March 20th, 2012]
- 017 The year of the dragon looks auspicious for Australian Biotechnology [Last Updated On: March 25th, 2012] [Originally Added On: March 25th, 2012]
- 018 Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation [Last Updated On: March 28th, 2012] [Originally Added On: March 28th, 2012]
- 019 Angel Biotechnology - Angel signs new contract with ReNeuron [Last Updated On: May 17th, 2012] [Originally Added On: May 17th, 2012]
- 020 Beike Earns AABB Accreditation for Cord Blood and Cord Tissue Banking [Last Updated On: May 29th, 2012] [Originally Added On: May 29th, 2012]
- 021 TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine [Last Updated On: June 25th, 2012] [Originally Added On: June 25th, 2012]
- 022 MYOS Names Veteran Biotechnology Executive Dr. Sol J. Barer to Chair Scientific Advisory Board [Last Updated On: June 27th, 2012] [Originally Added On: June 27th, 2012]
- 023 StemCells and Keryx Biopharmaceuticals Showing Strong Gains as Biotechnology Industry Soars in 2012 [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- 024 Allele Biotechnology Announces New Advance in Production of Human Stem Cells [Last Updated On: September 15th, 2012] [Originally Added On: September 15th, 2012]
- 025 BIO Announces Therapeutic Workshops for 11th Annual BIO Investor Forum [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- 026 Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and ... [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- 027 Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- 028 Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- 029 David Lichtenstein: Biotechnology is Rich Area for Investment [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- 030 26. Medical Biotechnology: Part Ic. Animal and Human Cloning and Genetic Engineering NQ - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- 031 Coare Biotechnology and ChemDiv Establish Co-Marketing and Service Collaboration [Last Updated On: November 8th, 2012] [Originally Added On: November 8th, 2012]
- 032 The Biotech Age: The Business Of Biotech And How To Profit From It - Richard Oliver - Video [Last Updated On: November 8th, 2012] [Originally Added On: November 8th, 2012]
- 033 blood banks | Umbilical Cord Blood Banking Could Be an Investment in Our Future Health - Video [Last Updated On: November 13th, 2012] [Originally Added On: November 13th, 2012]
- 034 Life Un(Ltd), Charis Thompson, Three Times a Woman- A Gendered Economy of Stem Cell Innovation Pt 1 - Video [Last Updated On: December 1st, 2012] [Originally Added On: December 1st, 2012]
- 035 Life UnLtd, Charis Thompson, Three Times a Woman A Gendered Economy of Stem Cell Innovation Pt 2 - Video [Last Updated On: December 1st, 2012] [Originally Added On: December 1st, 2012]
- 036 Biotechnology: Things you should know about Gene Therapy [Last Updated On: December 2nd, 2012] [Originally Added On: December 2nd, 2012]
- 037 Top trends for Biotechnology [Last Updated On: December 9th, 2012] [Originally Added On: December 9th, 2012]
- 038 What is exciting about Chemical Engineering? - Video [Last Updated On: December 20th, 2012] [Originally Added On: December 20th, 2012]
- 039 Things to know about the real fountain of youth [Last Updated On: January 20th, 2013] [Originally Added On: January 20th, 2013]
- 040 DNA testing is Good or Bad: Let’s Discuss [Last Updated On: March 10th, 2013] [Originally Added On: March 10th, 2013]
- 041 The Mystery about Cyanide Taste [Last Updated On: April 14th, 2013] [Originally Added On: April 14th, 2013]
- 042 Are Biodegradable Heart Stents Safe? [Last Updated On: April 21st, 2013] [Originally Added On: April 21st, 2013]
- 043 How good to use home pregnancy tests [Last Updated On: June 2nd, 2013] [Originally Added On: June 2nd, 2013]
- 044 Questions you should ask to doctor for Alzheimer disease [Last Updated On: July 7th, 2013] [Originally Added On: July 7th, 2013]
- 045 Matric Revision: Life Sciences: Genetics: Biotechnology (5/9): Cloning (1/4) - Video [Last Updated On: October 28th, 2013] [Originally Added On: October 28th, 2013]
- 046 Matric Revision: Life Sciences: Genetics: Biotechnology (6/9): Cloning (2/4) - Video [Last Updated On: October 28th, 2013] [Originally Added On: October 28th, 2013]
- 047 Adult Stem Cells Enhancer, From Fermented Biotechnology. - Video [Last Updated On: November 5th, 2013] [Originally Added On: November 5th, 2013]
- 048 Stem Cells Medical Applications of Biotechnology - Video [Last Updated On: January 30th, 2014] [Originally Added On: January 30th, 2014]
- 049 Biotechnology training for stem cell-related jobs265 - Video [Last Updated On: February 17th, 2014] [Originally Added On: February 17th, 2014]
- 050 Exciting business ideas in biotechnology and healthcare - Video [Last Updated On: February 18th, 2014] [Originally Added On: February 18th, 2014]
- 051 San Diego Hosts World's Largest Biotechnology Convention - Video [Last Updated On: June 25th, 2014] [Originally Added On: June 25th, 2014]
- 052 kineticvideo.com - Biotech 21st ethics-of-biotechnology-12540-4 - Video [Last Updated On: November 9th, 2014] [Originally Added On: November 9th, 2014]
- 053 HEMACORD Receives 2014 Prix Galien USA Best Biotechnology Product Award - Video [Last Updated On: December 8th, 2014] [Originally Added On: December 8th, 2014]
- 054 Omnigen S.A - Biotechnology - Video [Last Updated On: December 12th, 2014] [Originally Added On: December 12th, 2014]
- 055 DOXA: God of Wonders, Works...and Biotechnology - Video [Last Updated On: March 6th, 2015] [Originally Added On: March 6th, 2015]
- 056 BIOTECHNOLOGY ON EARTH - Video [Last Updated On: March 19th, 2015] [Originally Added On: March 19th, 2015]
- 057 Medzilla;Biotech Jobs, Pharmaceutical Jobs, Pharmaceutical ... [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 058 Biotechnology - Wikipedia, the free encyclopedia [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 059 Marx Biotechnology A disruptive technology that saves ... [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- 060 What is Biotechnology ? - Access Excellence [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- 061 Agricultural Biotechnology, Poverty Reduction, and Food ... [Last Updated On: June 2nd, 2015] [Originally Added On: June 2nd, 2015]
- 062 Biotechnology Industry Organization - Wikipedia, the free ... [Last Updated On: June 8th, 2015] [Originally Added On: June 8th, 2015]
- 063 biotechnology | Britannica.com [Last Updated On: June 10th, 2015] [Originally Added On: June 10th, 2015]
- 064 Biotechnology Salaries | Salary.com [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- 065 Role of Bacteria in Environment - Biotechnology Forums [Last Updated On: June 26th, 2015] [Originally Added On: June 26th, 2015]
- 066 What is Biotechnology? | BIO [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- 067 National Center for Biotechnology Information - Wikipedia ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- 068 Top 10 biotech companies and Top 100 biotechnology places ... [Last Updated On: July 5th, 2015] [Originally Added On: July 5th, 2015]
- 069 Biotechnology Careers in India : How to become a ... [Last Updated On: July 13th, 2015] [Originally Added On: July 13th, 2015]
- 070 Biotechnology [Last Updated On: August 3rd, 2015] [Originally Added On: August 3rd, 2015]
- 071 Hemolysin - Wikipedia, the free encyclopedia [Last Updated On: August 4th, 2015] [Originally Added On: August 4th, 2015]
- 072 What is biotechnology? - Definition from WhatIs.com [Last Updated On: August 10th, 2015] [Originally Added On: August 10th, 2015]
- 073 Portal:Biotechnology - Wikipedia, the free encyclopedia [Last Updated On: August 11th, 2015] [Originally Added On: August 11th, 2015]
- 074 History of biotechnology - Wikipedia, the free encyclopedia [Last Updated On: August 17th, 2015] [Originally Added On: August 17th, 2015]
- 075 What is Biotechnology? [Last Updated On: September 4th, 2015] [Originally Added On: September 4th, 2015]
- 076 Biotechnology News -- ScienceDaily [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- 077 Salt Lake Community College - Biotechnology [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 078 Biotechnology - Biomedical - Industrial Enzymes [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 079 Biotechnology - Center for Science in the Public Interest [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 080 Home - Biotechnology Programs [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]